Anocis Information

Anocis Therapeutics Ltd is a preclinical-stage biotech company advancing novel small treatments of pain and itch with low addiction potential. Our approaches address novel targets that modulate well-validated biological pathways. The experienced Anocis team have discovered multiple small molecules with favourable drug-like properties and full freedom to operate. These are now undergoing translational studies in clinically relevant models to support development candidate selection. We are currently seeking staged investment to expand screening in pain models, and to progress lead compounds into IND-enabling studies. Follow us for updates, or reach out if you’d like to discuss our science or investment opportunity.